Idefirix 11 mg powder for concentrate for solution for infusion, Delandistrogene moxeparvovec-rokl
SRP-9001-104
Phase 1 small_molecule active
Quick answer
Idefirix 11 mg powder for concentrate for solution for infusion, Delandistrogene moxeparvovec-rokl for Duchenne muscular dystrophy (DMD) is a Phase 1 program (small_molecule) at Sarepta Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Duchenne muscular dystrophy (DMD)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active